Therefore, it would be reasonable to postulate the observed reduction in S1P in WD patients may be due to copper-induced inhibition of SPHK1 by ROS, and this reduction may be involved in apoptotic mechanisms associated with WD. Here, SPHK1 is linked to Wilson disease.